Biotransformations of 4R-and 4 -hydroxyeudesmane derivatives by the filamentous fungus Gliocladium roseum were achieved. Hydroxylation at C-11 was the main action of this microorganism, producing new cryptomeridiol (12 and 14) and 4-epi-cryptomeridiol derivatives (6 and 7), respectively, in good yields. The biotransformation activity of G. roseum toward 4 -hydroxyeudesmane was focused on the isopropyl moiety, but more scattered on the 4R-hydroxylated derivative, acting in both the "A" and "B" rings and the isopropyl group of the molecule. Semisyntheses of 11-hydroxyeudesmanolides from the isolated 11,12-dihydroxylated metabolites were also accomplished and used in assigning the stereochemistry of hydroxylation.
Gliocladium roseum CECT 2733, the anamorphic form of Nectria ochroleuca IMI 40022, is a filamentous fungus that has been used previously to hydroxylate the sesquiterpene patchoulol, 1 to biotransform a derivative of the diterpene varodiol, to produce an ent-Ambrox derivative, 2 and to carry out the bioconversion of a 4 -hydroxyeudesmane derivative. 3 Eudesmane sesquiterpenes are common in nature, 4, 5 and in the past decade, several biotransformations of these kinds of compounds have been carried out to acquire products difficult to achieve by chemical means. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Cryptomeridiol is a natural sesquiterpene diol 17 that exerts a potent antispasmodic effect on the isolated rabbit ileum, 18 and 4-epi-cryptomeridiol is also a natural compound. 19 Sesquiterpene lactones show a wide variety of remarkable biological activities, but many of them present strong cytotoxic properties, apparently due to the R, -unsaturated lactone group. [20] [21] [22] [23] Some authors suspect that 11-hydroxysesquiterpenolides are the precursors of those compounds, and thus the unsaturated system could be released in small quantities, thereby attenuating the cytotoxic effect. 24 In previous papers 25, 26 we reported the incubations of several 4 -hydroxyeudesmane compounds by the filamentous fungi Curvularia lunata ATCC 12017 and Rhizopus nigricans ATCC 10404. The action of these microorganisms was directed mainly toward the isopropyl moiety; specifically, C. lunata was active toward C-12 and R. nigricans to C-11. Some of the best results were achieved on the 6 -acetoxy-1-keto derivative. Also we have described the incubations of some 4R-hydroxylated derivatives, 25, 26 but with poor transformation results. Therefore, in this study we have chosen 6 -acetoxy-1-keto derivatives that are 4 -or 4R-hydroxylated to carry out several biotransformations with the microorganism G. roseum.
Results and Discussion
6 -Acetoxy-4 -hydroxyeudesman-1-one (1) and its 4R-epimer compound (2) were obtained respectively, by Jones' oxidation at C-1, from the natural compounds 3 27 and 4. 28 Incubation of substrate 1 with G. roseum for 9 days yielded the metabolites 5 (3%), 6 (6%), 7 (58%), and 8 (4%).
Metabolite 5 had a molecular formula of C 17 H 26 O 5 , which indicated the presence of an additional oxygen atom and the absence of two hydrogen atoms in the molecule. Its 1 H NMR spectrum revealed two signals of an AB system at δ 2.69 and 2.47 (each 1H, d, J ) 4.9 Hz), characteristic of two geminal protons of an epoxide group. The absence of the signal for one of the methyls of the isopropyl group indicated that this epoxide group was situated at C-11 and C-12 in the molecule, this being confirmed by the analysis of its 13 C NMR spectrum. In conclusion, metabolite 5 was 6 -acetoxy-11,12-epoxy-4 -hydroxyeudesman-1-one. Due to the absence of a hydrogen atom at C-11 and the limited quantity available of this metabolite (5), we could not establish the configuration at this carbon.
Analysis of the spectral data of 6 suggested the insertion of a new hydroxyl group at C-11 and deacetylation at C-6. This metabolite, 4 ,6 ,11-trihydroxyeudesman-1-one (6), was a 4-epi-cryptomeridiol 19 derivative, which was previously obtained from the incubation of a eudesmane derivative with R. nigricans. 26 The main metabolite isolated (7) had a molecular formula of C 17 H 28 O 5 , which indicated the presence of an additional hydroxyl group in the molecule. The -effects on C-7, C-12, and C-13 detected in its 13 C NMR spectrum indicated that hydroxylation had occurred at C-11, establishing its structure as 6 -acetoxy-4 ,11-dihydroxyeudesman-1-one. This major metabolite (7) was also a 4-epicryptomeridiol 19 derivative, obtained from incubation of substrate 1 with R. nigricans. 26 The difference between metabolites 6 and 7 is the presence of an acetoxyl group at C-6 in the latter. Therefore, 7 should have eluted in the chromatographic separation before 6, but this did not occur perhaps due to a reduction in the expected polarity attributable to the formation of two hydrogen bonds between the three hydroxyl groups present in metabolite 6.
The molecular formula (C 15 H 26 O 5 ) of the last metabolite isolated (8) agreed with the presence of two new hydroxyl groups in the molecule and with the absence of an acetoxyl group at C-6. Comparisons of the 1 H NMR data of 8 with those of 6 revealed the presence of an AB system, centered at δ 3.67 and 3.32 (J ) 11.1 Hz), and the absence of one of the methyl signals of the isopropyl group. Therefore, these hydroxyl groups should be positioned at C-11 and C-12. Consequently, metabolite 8 is 4 ,6 ,11,12-tetrahydroxyeudesman-1-one. The configuration at C-11 was determined as "S" by the conversion of 8 into the corresponding 11-hydroxy-6 ,12-eudesmanolide (see below).
Incubation of substrate 2 with G. roseum for 15 days yielded the metabolites 9 (5%), 10 (9%), 11 (19%), 12 (32%), and 13 (4%) and a mixture of metabolites, from which, after treatment with LiAlH 4 , product 14 (4%) was isolated.
The IR spectrum of metabolite 9 indicated the presence of a carbon-carbon double bond (3080 and 1645 cm -1 ), and its 1 H NMR data confirmed a 2-propenyl group (δ 4.82, 1H, dd, J ) 1.5, 1.5 Hz; δ 4.69, 1H, br s; δ 1.76, 3H, br s) in the molecule. Therefore, a double bond between carbons 11 and 12 had been formed, probably by a dehydration reaction from an 11-hydroxyl compound. Metabolite 9 was therefore 6 -acetoxy-4R-hydroxyeudesm-11-en-1-one.
Metabolite 10 was the result of the stereoselective reduction of the keto group at C-1 of 1 from the face, giving a (1S)-hydroxylated derivative, as is usual in enzymatic reductions, 29 although this is difficult to achieve by chemical means. The "S" configuration at C-1 could easily be deduced from the signal in the 1 H NMR spectrum (δ 3.29, 1H, dd, J ) 3.0, 3.0 Hz), with coupling constants corresponding to an equatorial proton. Thus, metabolite 10 had the structure 6 -acetoxy-1R,4R-dihydroxyeudesmane.
The third metabolite isolated (11) had a molecular formula of C 17 H 28 O 5 , which indicated the presence of an additional hydroxyl group in the molecule. In its 1 H NMR spectrum a signal appeared at δ 4.12 (1H, ddd, J ) 11.2, 11.2, 4.1 Hz) due to an axial proton. The position of the new functional group at C-8 was determined by the -effects found on the adjacent carbons (C-7 and C-9). Therefore, metabolite 11 was 6 -acetoxy-4R,8R-dihydroxyeudesman-1-one.
Metabolite 12 had the same molecular formula as 11, and the spectral data suggested a new hydroxyl group at C-11. This major metabolite (12) was therefore the cryptomeridiol 17 derivative 6 -acetoxy-1-oxocryptomeridiol.
The molecular formula (C 17 H 28 O 6 ) of 13 indicated that the microorganism had introduced two hydroxyl groups in the molecule. The spectral data of 13 confirmed that the new hydroxyl groups were situated at C-11 and C-12 and that a rearrangement of the acetoxyl group at C-6 to the hydroxyl group at C-12 had taken place. Again, the configuration at C-11 was determined as "S" by the conversion of 13 into the corresponding 11-hydroxy-6 ,12-eudesmanolide (see below).
Finally, we could not separate a mixture of additional metabolites. Treatment of this mixture with LiAlH 4 enabled us to isolate product 14, in which reduction of the keto group at C-1 from the R-face (producing a 1 -alcohol) and the deacetylation of the acetoxyl group at C-6 had taken place. Product 14 showed spectral data that, by comparison with those of metabolites 11 and 12, positioned the new hydroxyl groups at C-8 and C-11. Hence, the structure of 14 was 1 ,6 ,8R-trihydroxycryptomeridiol.
In summary, G. roseum directed its principal action on this type of substrate toward carbon 11, producing 4R,11-and 4 ,11-dihydroxyeudesmane derivatives (cryptomeridiol 17 and 4-epi-cryptomeridiol 19 derivatives). The activity of this microorganism on 4 -hydroxyeudesmane (1) was focused on the isopropyl moiety, but was more scattered for the 4R-hydroxy derivative (2), acting in both the "A" and "B" rings and the isopropyl group of the molecule. The biotransformations carried out by both G. roseum and R. nigricans 26 on the 4 -hydroxylated substrate (1) yielded the 11-hydroxy derivative (7) as the main metabolite, although the former also produced an 11,12-dihydroxylated derivative (8) , which may be the precursor of an 11-hydroxyeudesmanolide. On the other hand, the main action on the substrate (1) by C. lunata 25 was the reduction of the carbonyl group at C-1, also producing a limited quantity of 12-hydroxylated derivatives. In addition, G. roseum effected a more efficient bioconversion of a 4R-hydroxylated eudesmane (2) than that achieved by C. lunata 25 or R. nigricans 26 with some 4R-hydroxylated eudesmane analogues.
Ley et al. have reported 30 that vicinal diols undergo glycol cleavage reactions with tetrapropylammonium perruthenate (TPAP) to give a carbonyl group. In the present study, we have investigated the reactions of 11,12-diol eudesmanes, with a third hydroxyl group at C-6, with TPAP. Instead of undergoing glycolytic cleavage, these substrates are oxidized to R-hydroxyl lactones. Starting from the 11,12-dihydroxylated metabolites, isolated in the biotransformation processes, we have thereby accomplished the semisyntheses of 11-hydroxyeudesmanolides (Figure 1) .
Treatment of metabolite 8 with TPAP gave 4 ,11R-dihydroxy-1-oxoeudesman-6 ,12-olide (15) . The configuration at C-11 was determined by a 2D NOESY experiment, due to the absence of a hydrogen atom in this carbon. This experiment demonstrated that the protons situated at C-8 and C-13 were spatially close, these results being compatible with an "11S" configuration for lactone 15 (Figure 2) . LiAlH 4 treatment of metabolite 13 led to product 16, which had undergone reduction of the keto group at C-1 and deacetylation of the acetoxyl group at C-12, as shown by spectral data. Therefore, 16 was 1 ,4R,6 ,11,12-pentahydroxyeudesmane. Polyalcohol derivative (16) was converted into the 11-hydroxyeudesmanolide 17 by reaction with TPAP. This product (17) was the result of the oxidation of the hydroxyl groups situated at C-1 and C-12, followed by a lactonization reaction. Consequently, 17 was 4R,11R-dihydroxy-1-oxoeudesman-6 ,12-olide. The configuration at C-11, and therefore of its precursor (16), was again established as "S" by the NOE effects observed between protons of C-8 and C-13 (see Figure 2) .
Experimental Section
General Experimental Procedures. Measurements of NMR spectra (300.13 MHz 1 H and 75.47 MHz 13 C) were made in CDCl3, CD3COCD3, or CD3OD (which also provided the lock signal) with Bruker spectrometers (AM-300, ARX-400, and AMX-500). The assignments of 13 C chemical shifts were made with the aid of distortionless enhancement by polarization transfer (DEPT) using a flip angle of 135°. One-dimensional NOE difference experiments were made by irradiation for 4 s in series of eight scans with alternation between on-and offresonance. Bruker's programs were used for COSY (GSMF), NOESY (TPFI), and C/H correlation (HMQC). IR spectra were recorded on a Nicolet 20SX FT-IR spectrometer. High-resolution mass spectra were made by LSIMS (FAB) ionization mode with a MICROMASS AUTOSPEC-Q spectrometer (EBE geometry). Uncorrected melting points were determined using a Kofler (Reichter) apparatus. Optical rotations were measured on a Perkin-Elmer 241 polarimeter at 25°C. Silica gel Scharlau 60 (40-60 µm) was used for flash chromatography. CH2Cl2 or CHCl3 containing increasing amounts of Me2CO or MeOH was used as eluent. Analytical plates (silica gel, Merck 60 G) were rendered visible by spraying with H2SO4-AcOH, followed by heating to 120°C. The identity of compounds 3 and 4 was confirmed by direct comparison with the authentic samples (IR, MS, NMR, etc.). Compounds 1 and 2 were obtained by oxidation of 3 and 4, respectively, with Jones' reagent (see Supporting Information).
Organism, Media, and Culture Conditions. Gliocladium roseum CECT 2733 was obtained from the Colección Españ ola de Cultivos Tipo, Departamento de Microbiología, Facultad de Ciencias, Universidad de Valencia, Spain, and was kept in YEPGA medium containing yeast extract (1%), peptone (1%), glucose (2%), and agar (2%) in H 2O at pH 5. In all transformation experiments a BEM medium containing peptone (0.1%), yeast extract (0.1%), beef extract (0.1%), and glucose (0.5%) in H2O at pH 5.7 was used. Erlenmeyer flasks (250 mL) containing 80 mL of medium were inoculated with a dense suspension of the corresponding microorganism. The cultures were incubated by shaking (150 rpm) at 28°C for 6 days, after which the substrates 1 and 2 (5-10%) in EtOH were added.
Biotransformation of 1. Substrate 1 (450 mg) was dissolved in EtOH (7 mL), distributed among seven Erlenmeyer flask cultures of G. roseum and incubated for 9 days, after which the cultures were filtered and pooled. The cells were washed thoroughly with H 2O, and the liquid was saturated with NaCl and extracted twice with CH2Cl2. Both extracts were pooled, dried with anhydrous Na2SO4, and evaporated at 40°C in a vacuum to give a mixture of compounds. This mixture was chromatographed on a silica gel column to obtain 42 mg (9%) of starting material 1, 12 mg (3%) of 6 -acetoxy-11,12-epoxy-4 -hydroxyeudesman-1-one (5), 24 mg (6%) of 4 ,6 ,11-trihydroxyeudesman-1-one (6), 26 276 mg (58%) of 6 -acetoxy-4 ,11-dihydroxyeudesman-1-one (7), 26 and 18 mg (4%) of (11S)-4 ,6 ,11,12-tetrahydroxyeudesman-1-one (8). Biotransformation of 2. Substrate 2 (450 mg) was dissolved in EtOH (7 mL), distributed among seven Erlenmeyer flask cultures of G. roseum and incubated for 15 days, after which the cultures were processed as indicated above for the biotransformation of 1, to give a mixture, which was chromatographed on a silica gel column to obtain 58 mg (13%) of starting material 2, 22 mg (5%) of 6 -acetoxy-4R-hydroxyeudesm-11-en-1-one (9), 43 mg (9%) of 6 -acetoxy-1R,4R-dihydroxyeudesmane (10), 92 mg (19%) of 6 -acetoxy-4R,8R-dihydroxyeudesman-1-one (11), 150 mg (32%) of 6 -acetoxy-4R,11-dihydroxyeudesman-1-one (12), 18 mg (4%) of (11S)-12-acetoxy-4R,6 ,11-trihydroxyeudesman-1-one (13) , and a mixture of metabolites, from which, after treatment with LiAlH 4, 1 ,4R,6 ,8R,11-pentahydroxyeudesmane (14, 19 mg, 4% of overall yield) was isolated. -4r-hydroxyeudesm-11-en-1-one (9 
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